Clinical Trial Update: Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating immunochemotherapy with or without salvage chemoradiation for local recurrence of Esophageal Squamous Cell Carcinoma afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Ye jinjun | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | Phase 3 | Status: ENROLLING_BY_INVITATION